The Cold-Eeze brand of products for cold sufferers can no longer be listed among the nationally sold consumer products owned by a Philadelphia-area company.
ProPhase Labs (NASDAQ: PRPH) completed its previously announced$50 million sale of the Cold-Eeze brand to Mylan after its shareholders approved the transaction Wednesday during a special assembly.
Cold-Eeze,first formulated as a zinc lozenge, expanded over the years into a variety of formulation consisting of gummies, oral sprays,caplets,…
Source: bizjournals.com